Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Download
Faster access than browser!
 

Brentuximab vedotin

Index Brentuximab vedotin

Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). [1]

50 relations: ABVD, Accelerated approval (FDA), Anaplastic large-cell lymphoma, Anemia, Antibody-drug conjugate, Biologics license application, Bleomycin, Boxed warning, Carbamate, Cathepsin B, CD30, Chemotherapy, Chemotherapy-induced peripheral neuropathy, CHOP, Citrulline, Clinical trial, Cutaneous T cell lymphoma, Cyclophosphamide, CYP3A4, Dacarbazine, Diffuse large B-cell lymphoma, Doxorubicin, European Medicines Agency, Food and Drug Administration, Fusion protein, Hodgkin's lymphoma, International nonproprietary name, Lysosome, Maleimide, Marketing authorization, Mitotic inhibitor, Monoclonal antibody, Monomethyl auristatin E, Mycosis fungoides, Neoplasm, Neutropenia, Non-Hodgkin lymphoma, Prednisolone, Prednisone, Progressive multifocal leukoencephalopathy, Relapse, Seattle Genetics, T cell, Therapy, Thrombocytopenia, Tubulin, Upper respiratory tract infection, Valine, Vinblastine, Vincristine.

ABVD

ABVD is a chemotherapy regimen used in the first-line treatment of Hodgkin lymphoma, supplanting the older MOPP protocol.

New!!: Brentuximab vedotin and ABVD · See more »

Accelerated approval (FDA)

The United States Food and Drug Administration (FDA) initiated the FDA Accelerated Approval Program in 1992 to allow faster approval of drugs for serious conditions that fill an unmet medical need.

New!!: Brentuximab vedotin and Accelerated approval (FDA) · See more »

Anaplastic large-cell lymphoma

Anaplastic large-cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma involving aberrant T cells or null lymphocytes.

New!!: Brentuximab vedotin and Anaplastic large-cell lymphoma · See more »

Anemia

Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.

New!!: Brentuximab vedotin and Anemia · See more »

Antibody-drug conjugate

Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer.

New!!: Brentuximab vedotin and Antibody-drug conjugate · See more »

Biologics license application

A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2).

New!!: Brentuximab vedotin and Biologics license application · See more »

Bleomycin

Bleomycin is a medication used to treat cancer. This includes Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, and cervical cancer among others. Typically used with other cancer medications, it can be given intravenously, by injection into a muscle or under the skin. It may also be administered inside the chest to help prevent the recurrence of a fluid around the lung due to cancer; however talc is better for this. Common side effects include fever, weight loss, vomiting, and rash. A severe type of anaphylaxis may occur. It may also cause inflammation of the lungs that can result in lung scarring. Chest X-rays every couple of weeks are recommended to check for this. Bleomycin may cause harm to the baby if used during pregnancy. It is believed to primarily work by preventing the making of DNA. Bleomycin was discovered in 1962. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication. The wholesale cost in the developing world is between 14 USD and 78 USD a dose. It is made by the bacterium Streptomyces verticillus.

New!!: Brentuximab vedotin and Bleomycin · See more »

Boxed warning

In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears on the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text.

New!!: Brentuximab vedotin and Boxed warning · See more »

Carbamate

A carbamate is an organic compound derived from carbamic acid (NH2COOH).

New!!: Brentuximab vedotin and Carbamate · See more »

Cathepsin B

Cathepsin B is in humans encoded by the CTSB gene.

New!!: Brentuximab vedotin and Cathepsin B · See more »

CD30

CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker.

New!!: Brentuximab vedotin and CD30 · See more »

Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.

New!!: Brentuximab vedotin and Chemotherapy · See more »

Chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive, enduring, and often irreversible condition featuring pain, numbness, tingling and sensitivity to cold in the hands and feet (sometimes progressing to the arms and legs) that afflicts between 30% and 40% of patients undergoing chemotherapy.

New!!: Brentuximab vedotin and Chemotherapy-induced peripheral neuropathy · See more »

CHOP

CHOP is the acronym for a chemotherapy regimen used in the treatment of non-Hodgkin lymphoma.

New!!: Brentuximab vedotin and CHOP · See more »

Citrulline

The organic compound citrulline is an α-amino acid.

New!!: Brentuximab vedotin and Citrulline · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

New!!: Brentuximab vedotin and Clinical trial · See more »

Cutaneous T cell lymphoma

Cutaneous T cell lymphoma (CTCL) is a class of non-Hodgkin lymphoma, which is a type of cancer of the immune system.

New!!: Brentuximab vedotin and Cutaneous T cell lymphoma · See more »

Cyclophosphamide

Cyclophosphamide (CP), also known as cytophosphane among other, is a medication used as chemotherapy and to suppress the immune system.

New!!: Brentuximab vedotin and Cyclophosphamide · See more »

CYP3A4

Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the intestine.

New!!: Brentuximab vedotin and CYP3A4 · See more »

Dacarbazine

Dacarbazine (DTIC), also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.

New!!: Brentuximab vedotin and Dacarbazine · See more »

Diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL or DLBL) is a cancer of B cells, a type of white blood cell responsible for producing antibodies.

New!!: Brentuximab vedotin and Diffuse large B-cell lymphoma · See more »

Doxorubicin

Doxorubicin, sold under the trade names Adriamycin among others, is a chemotherapy medication used to treat cancer.

New!!: Brentuximab vedotin and Doxorubicin · See more »

European Medicines Agency

The European Medicines Agency (EMA) is a European Union agency for the evaluation of medicinal products.

New!!: Brentuximab vedotin and European Medicines Agency · See more »

Food and Drug Administration

The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.

New!!: Brentuximab vedotin and Food and Drug Administration · See more »

Fusion protein

Fusion proteins or chimeric (\kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins.

New!!: Brentuximab vedotin and Fusion protein · See more »

Hodgkin's lymphoma

Hodgkin's lymphoma (HL) is a type of lymphoma which is generally believed to result from white blood cells of the lymphocyte kind.

New!!: Brentuximab vedotin and Hodgkin's lymphoma · See more »

International nonproprietary name

The International Nonproprietary Name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient.

New!!: Brentuximab vedotin and International nonproprietary name · See more »

Lysosome

A lysosome is a membrane-bound organelle found in nearly all animal cells.

New!!: Brentuximab vedotin and Lysosome · See more »

Maleimide

Maleimide is a chemical compound with the formula H2C2(CO)2NH (see diagram).

New!!: Brentuximab vedotin and Maleimide · See more »

Marketing authorization

Process of reviewing and assessing the dossier to support a medicinal product in view of its marketing (also called licensing, registration, approval, etc.), finalized by granting of a document also called marketing authorization (MA) (equivalent: product license).

New!!: Brentuximab vedotin and Marketing authorization · See more »

Mitotic inhibitor

A mitotic inhibitor is a drug that inhibits mitosis, or cell division.

New!!: Brentuximab vedotin and Mitotic inhibitor · See more »

Monoclonal antibody

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.

New!!: Brentuximab vedotin and Monoclonal antibody · See more »

Monomethyl auristatin E

Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent.

New!!: Brentuximab vedotin and Monomethyl auristatin E · See more »

Mycosis fungoides

Mycosis fungoides, also known as Alibert-Bazin syndrome or granuloma fungoides, is the most common form of cutaneous T-cell lymphoma.

New!!: Brentuximab vedotin and Mycosis fungoides · See more »

Neoplasm

Neoplasia is a type of abnormal and excessive growth of tissue.

New!!: Brentuximab vedotin and Neoplasm · See more »

Neutropenia

Neutropenia or neutropaenia is an abnormally low concentration of neutrophils (a type of white blood cell) in the blood.

New!!: Brentuximab vedotin and Neutropenia · See more »

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that includes all types of lymphoma except Hodgkin's lymphomas.

New!!: Brentuximab vedotin and Non-Hodgkin lymphoma · See more »

Prednisolone

Prednisolone is a steroid medication used to treat certain types of allergies, inflammatory conditions, autoimmune disorders, and cancers.

New!!: Brentuximab vedotin and Prednisolone · See more »

Prednisone

Prednisone is a synthetic glucocorticoid drug that is mostly used to suppress the immune system.

New!!: Brentuximab vedotin and Prednisone · See more »

Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy (PML) is a rare and usually fatal viral disease characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal).

New!!: Brentuximab vedotin and Progressive multifocal leukoencephalopathy · See more »

Relapse

In medicine, relapse or recidivism is a recurrence of a past (typically medical) condition.

New!!: Brentuximab vedotin and Relapse · See more »

Seattle Genetics

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.

New!!: Brentuximab vedotin and Seattle Genetics · See more »

T cell

A T cell, or T lymphocyte, is a type of lymphocyte (a subtype of white blood cell) that plays a central role in cell-mediated immunity.

New!!: Brentuximab vedotin and T cell · See more »

Therapy

Therapy (often abbreviated tx, Tx, or Tx) is the attempted remediation of a health problem, usually following a diagnosis.

New!!: Brentuximab vedotin and Therapy · See more »

Thrombocytopenia

Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.

New!!: Brentuximab vedotin and Thrombocytopenia · See more »

Tubulin

Tubulin in molecular biology can refer either to the tubulin protein superfamily of globular proteins, or one of the member proteins of that superfamily.

New!!: Brentuximab vedotin and Tubulin · See more »

Upper respiratory tract infection

Upper respiratory tract infections (URTI) are illnesses caused by an acute infection which involves the upper respiratory tract including the nose, sinuses, pharynx or larynx.

New!!: Brentuximab vedotin and Upper respiratory tract infection · See more »

Valine

Valine (symbol Val or V) is an α-amino acid that is used in the biosynthesis of proteins.

New!!: Brentuximab vedotin and Valine · See more »

Vinblastine

Vinblastine is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer.

New!!: Brentuximab vedotin and Vinblastine · See more »

Vincristine

Vincristine, also known as leurocristine and marketed under the brandname Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others. It is given intravenously. Most people experience some side effects from vincristine treatment. Commonly it causes a change in sensation, hair loss, constipation, difficulty walking, and headaches. Serious side effects may include neuropathic pain, lung damage, or low blood white cells. It will likely cause harm to the baby if given during pregnancy. It works by stopping cells from dividing properly. Vincristine was first isolated in 1961. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 1.80 and 42.60 USD per dose. It is a vinca alkaloid that can be obtained from the Madagascar periwinkle Catharanthus roseus.

New!!: Brentuximab vedotin and Vincristine · See more »

Redirects here:

ADCETRIS, ATC code L01XC12, ATCvet code QL01XC12, Adcetris, Brentuximab, ECHELON-1, SGN-35, Sgn35.

References

[1] https://en.wikipedia.org/wiki/Brentuximab_vedotin

OutgoingIncoming
Hey! We are on Facebook now! »